Virtus LifeSci Biotech Clinical Trials ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BBC and other ETFs, options, and stocks.

About BBC

BBC tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. 

Index-Tracked
FT Wilshire 5000 TR USD
Index-TrackedFT Wilshire 5000 TR USD
Category
Health
CategoryHealth
Number of holdings
127
Number of holdings127
Inception Date
Dec 16, 2014
Inception DateDec 16, 2014

BBC Key Statistics

AUM
38.19M
AUM38.19M
Price-Earnings ratio
-8.47
Price-Earnings ratio-8.47
30-Day yield
30-Day yield
Average volume
18.99K
Average volume18.99K
High today
$42.48
High today$42.48
Low today
$41.29
Low today$41.29
Open price
$41.50
Open price$41.50
Volume
17.83K
Volume17.83K
52 Week high
$44.10
52 Week high$44.10
52 Week low
$13.42
52 Week low$13.42
Expense ratio
0.79
Expense ratio0.79

Stock Snapshot

With a market cap of 38.04M, Virtus LifeSci Biotech Clinical Trials ETF(BBC) trades at $41.58. The stock has a price-to-earnings ratio of -8.47.

During the trading session on 2026-03-02, Virtus LifeSci Biotech Clinical Trials ETF(BBC) shares reached a daily high of $42.48 and a low of $41.29. At a current price of $41.58, the stock is +0.7% higher than the low and still -2.1% under the high.

Trading volume for Virtus LifeSci Biotech Clinical Trials ETF(BBC) stock has reached 17.83K, versus its average volume of 18.99K.

The stock's 52-week range extends from a low of $13.42 to a high of $44.10.

The stock's 52-week range extends from a low of $13.42 to a high of $44.10.

Average Annual Return

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.